These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 7075401)

  • 1. Biophysical identification and sorting of high metastatic variants from B16 melanoma tumor.
    Lessin SR; Abraham SR; Nicolini C
    Cytometry; 1982 May; 2(6):407-13. PubMed ID: 7075401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.
    Baniyash M; Netanel T; Witz IP
    Cancer Res; 1981 Feb; 41(2):433-7. PubMed ID: 7448787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.
    Poste G; Doll J; Hart IR; Fidler IJ
    Cancer Res; 1980 May; 40(5):1636-44. PubMed ID: 7370995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologically detectable MHC and tumor-associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors.
    Baniyash M; Smorodinsky NI; Yaakubovicz M; Witz IP
    J Immunol; 1982 Sep; 129(3):1318-23. PubMed ID: 7108209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants.
    Schroeder F; Gardiner JM
    Cancer Res; 1984 Aug; 44(8):3262-9. PubMed ID: 6146400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between post-replication repair and metastatic potential in B16 mouse melanoma cell lines.
    Khalil F; Hopp L
    Cytobios; 1985; 42(166):117-23. PubMed ID: 3996045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cell surface properties on the arrest of circulating melanoma cells.
    Poste G
    Prog Clin Biol Res; 1980; 41():737-45. PubMed ID: 7192863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
    Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and visualization of Met-72-positive, metastatic variants present in B16 melanoma tumor masses.
    Parratto NP; Kimura AK
    J Cell Biochem; 1988 Mar; 36(3):311-22. PubMed ID: 3379105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
    Nicolson GL; Dulski K; Basson C; Welch DR
    Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells.
    Watanabe H; Nabi IR; Raz A
    Cancer Res; 1991 May; 51(10):2699-705. PubMed ID: 2021948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of B16 melanoma cells with increased metastatic potential and low intercellular cohesion using Nuclepore filters.
    Tullberg KF; Burger MM
    Invasion Metastasis; 1985; 5(1):1-15. PubMed ID: 3980159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC; Gordon SG
    Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous sister chromatid exchange in metastatic variants of the murine B16 melanoma and human astrocytomas in culture.
    Lakshmi MS; Hunt G; Sherbet GV
    Invasion Metastasis; 1988; 8(4):205-16. PubMed ID: 3139579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.